Bu8 Sdn. Bhd. v. Creagri, Inc., C-14-4503-EMC
Decision Date | 06 March 2015 |
Docket Number | No. C-14-4503-EMC,C-14-4503-EMC |
Court | U.S. District Court — Northern District of California |
Parties | BU8 SDN. BHD., Petitioner, v. CREAGRI, INC., Respondent. |
On October 8, 2014, BU8 Sdn. Bhd. filed a petition to confirm an arbitration award (the "Award") entered against Respondent CreAgri Inc. The Award was issued in Singapore by an arbitrator applying Singapore law, pursuant to an arbitration clause contained in the relevant contract between BU8 and CreAgri.
Courts asked to confirm foreign arbitration awards "shall confirm the award" unless the party opposing confirmation can establish one of seven specific defenses. 9 U.S.C. § 207. As explained below, CreAgri cannot show that any of these limited defenses are applicable here, and thus the Court will confirm the Award.
Additionally, CreAgri cannot maintain any of its counterclaims in this action. According to the relevant contract, CreAgri agreed to arbitrate "any dispute or claim related to or arising out of" the contract. Because CreAgri's counterclaims are all "related to or arising out of" the relevantcontract, CreAgri was obligated to arbitrate these counterclaims, and may not maintain them in this forum.
Finally, BU8's request for attorneys' fees and costs associated with prosecuting this confirmation action is denied. Courts should only award attorneys' fees and costs when a party acts in bad faith in defending an action to confirm a foreign arbitral award. While CreAgri's arguments in opposition to confirmation of the award are without merit, the Court concludes it has not acted in bad faith sufficient to merit an award of attorneys' fees.
Petitioner BU8 is a Malaysian corporation whose business focuses on marketing and distributing health and wellness products. Docket No. 27 (CreAgri's Opposition to Motion to Confirm Arbitration Award) at 2. Respondent CreAgri is a California corporation that owns eight U.S. patents and eighteen international patents relating to HIDROX®, a health supplement derived from the pulp of olives that's typically used in food, dietary supplements, and skincare products. Id. at 3.
On October 6, 2010, CreAgri and BU8 entered into a joint venture agreement (the "JVA" or "Agreement") for the purpose of developing "a coordinated brand and marketing platform to commercialize human dietary supplements containing HIDROX to be sold specifically under the Olivenol Trademarks." Docket No. 1, Exhibit B (JVA) at Recitals.
As part of the JVA, the Parties established a new entity (the "JV Company"). CreAgri was assigned a 40% equity interest in the JV Company, and BU8 was assigned a 60% equity interest. Id. at ¶ 1.2. The Agreement included an exclusive license agreement:
CreAgri will grant an exclusive license to the JV Company of CreAgri IP for the JV Application, under commercially reasonable terms, including the right to sublicense, for (a) use [of] Hidrox for incorporation into the Olivenol Products, [and] (b) use of the Olivenol Trademarks, to promote, market, sell and/or distribute the Olivenol Products.
Id. at ¶ 2.3(ii). The JVA defines "CreAgri IP" as CreAgri's "proprietary rights in hydroxytyrosol-rich formulations derived from the pulp of olives (HIDROX), as well as proprietary technology andknow-how to produce HIDROX (such intellectual property in existence as of the effective date of this Agreement)." Id. at Recitals.
The JVA contains an arbitration clause that provides that "any dispute or claim related to or arising out of this Agreement, or the interpretation, making, performance, breach or termination thereof" shall be resolved in Singapore according to Singapore law "by arbitration in accordance with the then Arbitration Rules of the Singapore International Arbitration Centre ('SIAC Rules')." Id. at ¶ 9.3. It further states that "any final decision issued in arbitration shall be binding and conclusive upon the parties to this Agreement and may be entered as a final judgment by any court of competent jurisdiction." Id.
On October 12, 2012, the parties jointly nominated an arbitrator to address their disputes regarding the interpretation of the JVA and any alleged breaches of the Agreement. Docket No. 1, Exhibit A (Arbitration Award) ("Award") at 4, 46-49. Pursuant to the JVA, the arbitration was held in Singapore, administered by SIAC under its Arbitration rules, and was conducted according to Singapore law. Id. at 4. The arbitrator issued the Award on August 12, 2014. Id. at 103.
In general, the Award purports to enforce the exclusive license agreement of the JVA by prohibiting CreAgri from licensing or otherwise distributing human dietary supplements containing HIDROX with third parties. Id. at 101-102. Moreover, the Award provides that CreAgri shall remit an appropriate share of any proceeds it obtains from such third-party agreements, such as one between CreAgri and Cosway.1 Id. at 101-102. Specifically, the Award requires CreAgri to notify BU8 of all profits it has received from the Cosway supply agreement and pay BU8 60% of those net profits. Id. at 102.
The Award also provided CreAgri additional time to exercise its right to subscribe to further shares in the JV Company.2 Id. at 103. Lastly, the Award requires CreAgri to pay for legal costs incurred by BU8 in connection with the arbitration. Id.
BU8 filed this action to confirm the Award on October 8, 2014. Docket No. 1. On December 9, 2014, CreAgri filed an amended answer opposing BU8's petition to confirm the Award. Docket No. 14. CreAgri's answer contains several putative defenses as well as counterclaims. Id. On January 15, 2014, BU8 filed an omnibus motion to confirm the arbitration award, to strike all of CreAgri's pleadings,3 to dismiss its counterclaims, and for an of award attorneys' fees and costs. Docket No. 15 (BU8's Omnibus Motion) ("Mot."). This Court heard oral argument on BU8's motion on February 12, 2015. Docket No. 37.
The United Nations Convention on the Recognition and Enforcement of Foreign Arbitral Awards ("Convention") governs the "recognition and enforcement" of all foreign arbitral awards in United States courts. 9 U.S.C. § 201 ( ).
Under the Convention, a district court "shall" confirm a foreign arbitration award unless the party opposing confirmation can establish one of the defenses enumerated in Article V of the Convention. 9 U.S.C. § 207 (); see also Admart AG v. Stephen & Mary Birch Found., Inc., 457 F.3d 302, 307 (3d Cir. 2006) ( ). Specifically, the Court may only refuse to confirm an arbitration if the party resisting confirmation can prove:
Public policy strongly favors confirmation of international arbitration awards. Polimaster Ltd. v. RAE Sys., Inc., 623 F.3d 832, 836 (9th Cir. 2010). As the Second Circuit once observed, "[e]xtensive judicial review frustrates the basic purpose of arbitration, which is to dispose of disputes quickly and avoid the expense and delay of extended court proceedings." Parsons & Whittemore Overseas Co. v. Societe Generale De L'Industrie Du Papier (RAKTA), 508 F.2d 969, 977 (2d Cir. 1974) (internal citations omitted). Thus, confirmation proceedings are necessarily"summary" in nature and are "not intended to involve complex factual determinations, other than a determination of the limited statutory conditions for confirmation or grounds for refusal to confirm." Marker Volkl (Int'l) GmbH v. Epic Sports Int'l, Inc., 965 F. Supp. 2d 308, 311 (S.D.N.Y. 2013).
The party defending against enforcement of the award has the burden to prove one of the Convention's enumerated defenses. Empresa Constructora Contex Limitada v. Iseki, Inc., 106 F. Supp. 2d 1020, 1024 (S.D. Cal. 2000); see...
To continue reading
Request your trial